The Science 

67 Yonge Street, Suite 701. Toronto, ON. Canada.


Product analytics answers your questions

Maecenas varius nunc a odio ultrices, non consectetur nunc scelerisque. Mauris nec condimentum est, id eleifend orci.

Better understand you customers

Explain the features and what it acompolishes. What does your company offer that will improve or solve a problem?


© 2020 Neurolytixs Inc All rights reserved


Neurolytixs leverages artificial intelligence to easily, quickly and precisely diagnose concussions with 96% accuracy within 48 hours of an incident using a finger prick

Improve acquisition

Lacinia condimentum lectus dolor viverra nunc. Mauris quis condimentum orci. Curabitur hendrerit, felis vitae.

Drive customer retention

Curabitur quis purus congue ante interdum mattis sit amet at ante. Nulla volutpat, magna quis convallis tristique.

Incident Test

Shipping to a Neurolytixs laboratory


Incident test using a finger prick

Preventive removal from play after incident 


Baseline Test

Baseline test using a finger prick

Shipping to a Neurolytixs laboratory

Secure storage

Dr. Douglas Fraser

DISCLAIMER: Neurolytixs is based on research to date and has not been reviewed by FDA or Health Canada. At the moment, Neurolytixs is an R&D company and is not to be used for concussion diagnosis

© 2020 Neurolytixs Inc All rights reserved

“This product has been 6 years in the making and amongst field experts, it is considered the “Holy Grail” of traumatic brain injury research.”

The Problem

In Canada, 452 people experience a traumatic brain injury (mTBI) every single day – roughly one person every three minutes. Concussions threaten the long-term brain health of children, amateur athletes, and military personnel.

Today, more than 10% of young athletes experience a concussion every year and an astounding 50% of concussions in youth sports go undiagnosed. Up to 20% of military personnel deployed to Iraq or Afghanistan experienced an mTBI while deployed and up to one-third continue to experience persistent symptoms.

Currently, concussions are diagnosed subjectively through physical, cognitive, and behavioural methodologies, which can be misinterpreted and manipulated. Left untreated, concussions can affect a person’s health and quality of life for the rest of their life.

The Potential

Clinical scientists at Neurolytixs have discovered a way to fundamentally change the way concussions are diagnosed in amateur sports and active duty: with a prick of a finger. The first test of its kind to yield accurate results, the simple finger-prick blood test leverages artificial intelligence to help diagnose concussions. Neurolytixs provides rapid and accurate diagnostics for mild traumatic brain injury (mTBI) using dried plasma spot and metabolite measurements via a mass spectrometer.

The Tool: A two-step diagnostic process that is fast and efficient

Patients (such as athletes, soldiers, children, etc.) document their “chemical fingerprint” by submitting a baseline blood sample at the start of the season. This baseline is important as it provides the most accurate, personalized assessment for patients.

Step 1:

If a possible concussion occurs, a new finger-prick blood sample is then sent to the lab for testing within a 72-hour window post-incident and is compared with the athlete’s original baseline sample. This step can accurately determine if the individual has had a concussion or not within 20 minutes.

Step 2:

This diagnostic tool will help remove injured athletes from play, preventing further acute injury, and supporting stronger strategies to help concussion patients recover. In training settings and deployment for Canadian Armed Forces members, this technology can be life-saving for our military personnel following blast injury.

PatentsNewsScienceAbout UsHome